Sign inGet started

VICL

VICAL INCCIK 819050 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
18

AI insights for VICL PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for VICL
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

InsiderRoleTradesBoughtSoldLast trade
Boyd Steven10% Owner27$207.4K$1.93M2019-01-10
Armistice Capital Master Fund Ltd.10% Owner45$2.39M$02018-06-28
SAMANT VIJAY BPresident & CEO63$544.2K$202.6K2018-06-18
Beleson Richard MDirector9$70$02018-05-23
SHENK THOMAS EDirector5$0$02018-05-23
MERTON ROBERT CDirector20$189.2K$18.5K2018-05-23
DOUGLAS R GORDONDirector13$44.6K$24.1K2018-05-23
LYONS GARY ADirector13$31.2K$16.3K2018-05-23
MORROW GEORGE JDirector11$123$02018-05-23
Mammen MammenSr VP, Clinical Development3$0$02018-01-08
SMITH LAWRENCE RUSSELLVP, Vaccine Research33$127.8K$43.1K2018-01-08
Ramos Anthony AlanVP, Chief Financial Officer43$99.7K$38.6K2018-01-08
BILINSKY IGORSr VP, Corporate Development16$127.8K$23.6K2015-07-13
SHERWIN STEPHEN ADirector6$70$02015-05-21
SINGER JAMES R10% Owner53$12.02M$2.28M2013-09-12
ROLLAND ALAIN P PHDExec VP, Product Development30$491$02013-08-22
Broadfoot Jill MarieSr Vice President, CFO, Sec8$541$02013-04-01
CAMPBELL ROBERT HDirector16$73$02012-10-25

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
Boyd Steven10% Owner S Sale2019-01-102019-01-140— $02,170,000SEC↗
Boyd Steven10% Owner S Sale2019-01-102019-01-140— $02,170,000SEC↗
Boyd Steven10% Owner S Sale2019-01-102019-01-142,190,500$0.88 $1.93M2,170,000SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-282018-07-020— $04,360,000SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-282018-07-020— $04,360,000SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-282018-07-0225,606$1.21 $31.0K4,360,000SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-282018-07-020— $04,334,394SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-282018-07-020— $04,334,394SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-282018-07-020— $04,360,500SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-282018-07-02500$1.19 $5954,360,500SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-282018-07-020— $04,360,500SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-282018-07-020— $04,198,794SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-282018-07-020— $04,198,794SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-282018-07-02135,600$1.21 $164.1K4,334,394SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-282018-07-02998,794$1.20 $1.20M4,198,794SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-282018-07-020— $03,200,000SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-282018-07-020— $03,200,000SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-282018-07-02116,091$1.21 $140.5K3,200,000SEC↗
Boyd Steven10% Owner P Buy2018-06-272018-06-272,600$1.25 $3.3K3,054,479SEC↗
Boyd Steven10% Owner P Buy2018-06-272018-06-270— $03,083,909SEC↗
Boyd Steven10% Owner P Buy2018-06-272018-06-270— $03,083,909SEC↗
Boyd Steven10% Owner P Buy2018-06-272018-06-271,000$1.21 $1.2K3,083,909SEC↗
Boyd Steven10% Owner P Buy2018-06-272018-06-270— $03,082,909SEC↗
Boyd Steven10% Owner P Buy2018-06-272018-06-270— $03,082,909SEC↗
Boyd Steven10% Owner P Buy2018-06-272018-06-2728,430$1.23 $35.0K3,082,909SEC↗
Boyd Steven10% Owner P Buy2018-06-272018-06-270— $03,054,479SEC↗
Boyd Steven10% Owner P Buy2018-06-272018-06-270— $03,054,479SEC↗
Boyd Steven10% Owner P Buy2018-06-262018-06-270— $03,051,879SEC↗
Boyd Steven10% Owner P Buy2018-06-262018-06-270— $03,051,879SEC↗
Boyd Steven10% Owner P Buy2018-06-262018-06-279,103$1.24 $11.3K3,051,879SEC↗
Boyd Steven10% Owner P Buy2018-06-252018-06-270— $03,042,776SEC↗
Boyd Steven10% Owner P Buy2018-06-252018-06-270— $03,042,776SEC↗
Boyd Steven10% Owner P Buy2018-06-252018-06-2710,672$1.26 $13.4K3,042,776SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-222018-06-2214,520$1.25 $18.1K3,032,104SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-222018-06-220— $03,032,104SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-222018-06-220— $03,032,104SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-212018-06-220— $03,017,584SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-212018-06-220— $03,017,584SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-212018-06-22140$1.25 $1753,017,584SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-202018-06-220— $03,017,444SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-202018-06-223,702$1.27 $4.7K3,017,444SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-202018-06-220— $03,017,444SEC↗
SAMANT VIJAY BPresident & CEO A Award deriv2018-06-182018-06-19105,000— $0105,000SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-182018-06-180— $03,013,742SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-182018-06-180— $03,013,742SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-182018-06-1813,742$1.20 $16.5K3,013,742SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-142018-06-180— $03,000,000SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-142018-06-180— $03,000,000SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-142018-06-1829,103$1.15 $33.5K3,000,000SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-132018-06-13145,297$1.07 $155.5K2,970,897SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-132018-06-130— $02,970,897SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-132018-06-130— $02,970,897SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-122018-06-130— $02,800,000SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-122018-06-130— $02,800,000SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-122018-06-13131,295$1.23 $161.5K2,800,000SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-122018-06-1325,600$1.08 $27.6K2,825,600SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-122018-06-130— $02,825,600SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-122018-06-130— $02,825,600SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-112018-06-130— $02,668,705SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-112018-06-130— $02,668,705SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-112018-06-1368,705$1.21 $83.1K2,668,705SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-112018-06-130— $02,600,000SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-112018-06-130— $02,600,000SEC↗
Armistice Capital Master Fund 10% Owner P Buy2018-06-112018-06-13300,000$1.18 $354.0K2,600,000SEC↗
SHENK THOMAS EDirector A Award deriv2018-05-232018-05-246,500— $06,500SEC↗
DOUGLAS R GORDONDirector A Award deriv2018-05-232018-05-248,000— $08,000SEC↗
LYONS GARY ADirector A Award deriv2018-05-232018-05-246,500— $06,500SEC↗
MORROW GEORGE JDirector A Award deriv2018-05-232018-05-246,500— $06,500SEC↗
Beleson Richard MDirector A Award deriv2018-05-232018-05-246,500— $06,500SEC↗
MERTON ROBERT CDirector A Award deriv2018-05-232018-05-246,500— $06,500SEC↗
Boyd Steven10% Owner P Buy2018-01-222018-01-260— $02,280,000SEC↗
Boyd Steven10% Owner P Buy2018-01-222018-01-2635,000$1.42 $49.7K2,235,000SEC↗
Boyd Steven10% Owner P Buy2018-01-222018-01-260— $02,235,000SEC↗
Boyd Steven10% Owner P Buy2018-01-222018-01-260— $02,300,000SEC↗
Boyd Steven10% Owner P Buy2018-01-222018-01-260— $02,300,000SEC↗
Boyd Steven10% Owner P Buy2018-01-222018-01-2620,000$1.46 $29.2K2,300,000SEC↗
Boyd Steven10% Owner P Buy2018-01-222018-01-260— $02,280,000SEC↗
Boyd Steven10% Owner P Buy2018-01-222018-01-2645,000$1.43 $64.3K2,280,000SEC↗
Boyd Steven10% Owner P Buy2018-01-222018-01-260— $02,235,000SEC↗
SMITH LAWRENCE RUSSELLSr VP, Research A Award deriv2018-01-082018-01-108,467— $08,467SEC↗
SMITH LAWRENCE RUSSELLSr VP, Research A Award deriv2018-01-082018-01-1051,533— $051,533SEC↗
Ramos Anthony AlanVP, Chief Financial Officer A Award deriv2018-01-082018-01-1014,562— $014,562SEC↗
Ramos Anthony AlanVP, Chief Financial Officer A Award deriv2018-01-082018-01-1055,438— $055,438SEC↗
Mammen MammenSr VP, Clinical Development A Award deriv2018-01-082018-01-1057,158— $057,158SEC↗
Mammen MammenSr VP, Clinical Development A Award deriv2018-01-082018-01-1012,842— $012,842SEC↗
SAMANT VIJAY BPresident & CEO A Award deriv2018-01-082018-01-1036,775— $036,775SEC↗
SAMANT VIJAY BPresident & CEO A Award deriv2018-01-082018-01-1068,225— $068,225SEC↗
MERTON ROBERT CDirector P Buy2017-11-102017-11-1485,700$1.75 $150.0K95,451SEC↗
SAMANT VIJAY BPresident & CEO A Award deriv2017-05-252017-05-3025,000— $025,000SEC↗
SMITH LAWRENCE RUSSELLSr VP, Research A Award deriv2017-05-252017-05-3010,000— $010,000SEC↗
Ramos Anthony AlanVP, Chief Financial Officer A Award deriv2017-05-252017-05-3010,000— $010,000SEC↗
LYONS GARY ADirector A Award deriv2017-05-252017-05-306,500— $06,500SEC↗
MERTON ROBERT CDirector A Award deriv2017-05-252017-05-306,500— $06,500SEC↗
MORROW GEORGE JDirector A Award deriv2017-05-252017-05-306,500— $06,500SEC↗
Beleson Richard MDirector A Award deriv2017-05-252017-05-306,500— $06,500SEC↗
Mammen MammenSr VP, Clinical Development A Award deriv2017-05-252017-05-3010,000— $010,000SEC↗
DOUGLAS R GORDONDirector A Award deriv2017-05-252017-05-308,000— $08,000SEC↗
SHENK THOMAS EDirector A Award deriv2017-05-252017-05-316,500— $06,500SEC↗
Ramos Anthony AlanVP, Chief Accounting Officer S Sale2017-03-272017-03-284,250$2.17 $9.2K9,674SEC↗
SMITH LAWRENCE RUSSELLVP, Vaccine Research S Sale2017-03-152017-03-17875$2.31 $2.0K17,696SEC↗
SMITH LAWRENCE RUSSELLVP, Vaccine Research S Sale2017-02-102017-02-144,500$2.26 $10.2K18,571SEC↗
SAMANT VIJAY BPresident & CEO S Sale2017-02-012017-02-033,750$2.16 $8.1K87,420SEC↗
Ramos Anthony AlanVP, Chief Accounting Officer A Award deriv2017-01-122017-01-17787— $020,000SEC↗
Ramos Anthony AlanVP, Chief Accounting Officer A Award deriv2017-01-122017-01-1719,213— $019,213SEC↗
Ramos Anthony AlanVP, Chief Accounting Officer A Award deriv2017-01-122017-01-1725,000— $025,000SEC↗
SMITH LAWRENCE RUSSELLVP, Vaccine Research A Award deriv2017-01-122017-01-1718,823— $018,823SEC↗
SMITH LAWRENCE RUSSELLVP, Vaccine Research A Award deriv2017-01-122017-01-171,177— $020,000SEC↗
SMITH LAWRENCE RUSSELLVP, Vaccine Research A Award deriv2017-01-122017-01-1725,000— $025,000SEC↗
SAMANT VIJAY BPresident & CEO A Award deriv2017-01-122017-01-1780,000— $080,000SEC↗
SAMANT VIJAY BPresident & CEO A Award deriv2017-01-122017-01-1728,146— $028,146SEC↗
SAMANT VIJAY BPresident & CEO A Award deriv2017-01-122017-01-1721,854— $050,000SEC↗
SMITH LAWRENCE RUSSELLVP, Vaccine Research S Sale2017-01-112017-01-1354$2.48 $13423,071SEC↗
SAMANT VIJAY BPresident & CEO S Sale2017-01-102017-01-125,763$2.45 $14.1K91,170SEC↗
MERTON ROBERT CDirector S Sale2016-12-222016-12-222,000$2.26 $4.5K9,751SEC↗
MERTON ROBERT CDirector S Sale2016-12-212016-12-222,000$2.22 $4.4K11,751SEC↗
MERTON ROBERT CDirector S Sale2016-12-202016-12-202,000$2.22 $4.4K13,751SEC↗
MERTON ROBERT CDirector S Sale2016-12-192016-12-202,327$2.21 $5.1K15,751SEC↗
SAMANT VIJAY BPresident & CEO S Sale2016-12-132016-12-134,649$2.40 $11.2K96,933SEC↗
DOUGLAS R GORDONDirector S Sale2016-12-122016-12-1310,078$2.39 $24.1K10,828SEC↗
SAMANT VIJAY BPresident & CEO S Sale2016-12-122016-12-1311,050$2.39 $26.4K101,582SEC↗
LYONS GARY ADirector S Sale2016-12-052016-12-077,078$2.30 $16.3K7,828SEC↗
SMITH LAWRENCE RUSSELLVP, Vaccine Research S Sale2016-10-112016-10-1254$3.05 $16523,125SEC↗
SMITH LAWRENCE RUSSELLVP, Vaccine Research S Sale2016-07-112016-07-1354$4.46 $24123,179SEC↗
MERTON ROBERT CDirector P Buy2016-06-142016-06-144,100$4.41 $18.1K18,078SEC↗
MERTON ROBERT CDirector P Buy2016-06-132016-06-144,900$4.29 $21.0K13,978SEC↗
SAMANT VIJAY BPresident & CEO P Buy2016-06-092016-06-1015,700$4.72 $74.1K112,632SEC↗
DOUGLAS R GORDONDirector P Buy2016-06-062016-06-0810,078$4.41 $44.4K20,906SEC↗
LYONS GARY ADirector P Buy2016-06-032016-06-067,078$4.39 $31.1K14,906SEC↗
SHENK THOMAS EDirector A Award deriv2016-05-202016-05-2465,000— $065,000SEC↗
Beleson Richard MDirector A Award deriv2016-05-202016-05-2465,000— $065,000SEC↗
MERTON ROBERT CDirector A Award deriv2016-05-202016-05-2465,000— $065,000SEC↗
MORROW GEORGE JDirector A Award deriv2016-05-202016-05-2465,000— $065,000SEC↗
LYONS GARY ADirector A Award deriv2016-05-202016-05-2465,000— $065,000SEC↗
DOUGLAS R GORDONDirector A Award deriv2016-05-202016-05-2480,000— $080,000SEC↗
SAMANT VIJAY BPresident & CEO A Award deriv2016-05-202016-05-24212,500— $0212,500SEC↗
SMITH LAWRENCE RUSSELLVP, Vaccine Research S Sale2016-03-152016-03-178,750$0.41 $3.6K232,331SEC↗
SAMANT VIJAY BPresident & CEO S Sale2016-03-032016-03-035,900$0.37 $2.2K969,326SEC↗
SAMANT VIJAY BPresident & CEO S Sale2016-03-022016-03-0314,000$0.37 $5.2K975,226SEC↗
SAMANT VIJAY BPresident & CEO S Sale2016-03-012016-03-0317,600$0.35 $6.2K989,226SEC↗
Ramos Anthony AlanVP, Chief Accounting Officer S Sale2016-02-192016-02-227,500$0.33 $2.5K139,235SEC↗
Ramos Anthony AlanVP, Chief Accounting Officer S Sale2016-01-252016-01-26193$0.35 $68146,735SEC↗
SMITH LAWRENCE RUSSELLVP, Vaccine Research A Award deriv2016-01-152016-01-1520,071— $0250,000SEC↗
SMITH LAWRENCE RUSSELLVP, Vaccine Research A Award deriv2016-01-152016-01-15229,929— $0229,929SEC↗
Ramos Anthony AlanVP, Chief Accounting Officer A Award deriv2016-01-152016-01-1567,888— $0300,000SEC↗
Ramos Anthony AlanVP, Chief Accounting Officer A Award deriv2016-01-152016-01-15232,112— $0232,112SEC↗
SAMANT VIJAY BPresident & CEO A Award deriv2016-01-152016-01-15199,244— $0425,000SEC↗
SAMANT VIJAY BPresident & CEO A Award deriv2016-01-152016-01-15225,756— $0225,756SEC↗
SAMANT VIJAY BPresident & CEO S Sale2016-01-122016-01-1311,202$0.35 $3.9K1,006,826SEC↗
SMITH LAWRENCE RUSSELLVP, Vaccine Research S Sale2016-01-112016-01-13974$0.36 $351241,081SEC↗
SAMANT VIJAY BPresident & CEO S Sale2016-01-112016-01-1348,535$0.35 $17.0K1,018,028SEC↗
SAMANT VIJAY BPresident & CEO S Sale2016-01-072016-01-0875,000$0.36 $27.0K1,066,563SEC↗
SHENK THOMAS EDirector A Award deriv2015-12-182015-12-2260,000— $060,000SEC↗
SHENK THOMAS EDirector A Award2015-12-182015-12-2210,000$0.01 $10010,000SEC↗
Ramos Anthony AlanVP, Chief Accounting Officer S Sale2015-10-232015-10-27193$0.39 $75146,928SEC↗
SAMANT VIJAY BPresident & CEO S Sale2015-10-122015-10-144,738$0.41 $1.9K1,141,563SEC↗
SMITH LAWRENCE RUSSELLVP, Vaccine Research S Sale2015-10-122015-10-14974$0.43 $419242,055SEC↗
Ramos Anthony AlanVP, Chief Accounting Officer S Sale2015-07-232015-07-27194$0.62 $120147,121SEC↗
BILINSKY IGORSr VP, Corporate Development S Sale2015-07-132015-07-151,258$0.70 $881193,798SEC↗
SAMANT VIJAY BPresident & CEO S Sale2015-07-132015-07-154,737$0.70 $3.3K1,146,301SEC↗
SMITH LAWRENCE RUSSELLVP, Vaccine Research S Sale2015-07-132015-07-15974$0.70 $682243,029SEC↗
SAMANT VIJAY BPresident & CEO A Award deriv2015-05-212015-05-26125,000— $0125,000SEC↗
DOUGLAS R GORDONDirector A Award deriv2015-05-212015-05-2665,000— $065,000SEC↗
MERTON ROBERT CDirector A Award deriv2015-05-212015-05-2650,000— $050,000SEC↗
LYONS GARY ADirector A Award deriv2015-05-212015-05-2650,000— $050,000SEC↗
Beleson Richard MDirector A Award deriv2015-05-212015-05-2650,000— $050,000SEC↗
SHERWIN STEPHEN ADirector A Award deriv2015-05-212015-05-2650,000— $050,000SEC↗
MORROW GEORGE JDirector A Award deriv2015-05-212015-05-2650,000— $050,000SEC↗
DOUGLAS R GORDONDirector A Award2015-05-212015-05-267,500$0.01 $75108,281SEC↗
MERTON ROBERT CDirector A Award2015-05-212015-05-267,500$0.01 $7590,781SEC↗
LYONS GARY ADirector A Award2015-05-212015-05-267,500$0.01 $7578,281SEC↗
Beleson Richard MDirector A Award2015-05-212015-05-267,500$0.01 $7522,078SEC↗
SHERWIN STEPHEN ADirector A Award2015-05-212015-05-267,500$0.01 $7522,003SEC↗
MORROW GEORGE JDirector A Award2015-05-212015-05-267,500$0.01 $7527,347SEC↗
Ramos Anthony AlanVP, Chief Accounting Officer S Sale2015-04-232015-04-27193$1.01 $195147,315SEC↗
BILINSKY IGORSr VP, Corporate Development S Sale2015-04-132015-04-151,257$0.93 $1.2K195,056SEC↗
SMITH LAWRENCE RUSSELLVP, Vaccine Research S Sale2015-04-132015-04-15974$0.93 $906244,003SEC↗
SAMANT VIJAY BPresident & CEO S Sale2015-04-132015-04-154,738$0.93 $4.4K1,151,038SEC↗
SAMANT VIJAY BPresident & CEO S Sale2015-03-302015-04-0155,000$0.91 $50.0K1,155,776SEC↗
Ramos Anthony AlanVP, Chief Accounting Officer S Sale2015-01-212015-01-22428$1.09 $467147,508SEC↗
SMITH LAWRENCE RUSSELLVP, Vaccine Research A Award deriv2015-01-192015-01-2167,500— $067,500SEC↗
SMITH LAWRENCE RUSSELLVP, Vaccine Research A Award deriv2015-01-192015-01-2152,500— $0120,000SEC↗
SAMANT VIJAY BPresident & CEO A Award deriv2015-01-192015-01-21171,606— $0250,000SEC↗
SAMANT VIJAY BPresident & CEO A Award deriv2015-01-192015-01-2178,394— $078,394SEC↗
BILINSKY IGORSr VP, Corporate Development A Award deriv2015-01-192015-01-2161,249— $0140,000SEC↗
BILINSKY IGORSr VP, Corporate Development A Award deriv2015-01-192015-01-2178,751— $078,751SEC↗
Ramos Anthony AlanVP, Chief Accounting Officer A Award deriv2015-01-192015-01-2143,750— $0100,000SEC↗
Ramos Anthony AlanVP, Chief Accounting Officer A Award deriv2015-01-192015-01-2156,250— $056,250SEC↗
SMITH LAWRENCE RUSSELLVP, Vaccine Research A Award2015-01-192015-01-2170,000$0.01 $700244,977SEC↗
SAMANT VIJAY BPresident & CEO A Award2015-01-192015-01-21300,000$0.01 $3.0K1,210,776SEC↗
BILINSKY IGORSr VP, Corporate Development A Award2015-01-192015-01-2170,000$0.01 $700196,313SEC↗
Ramos Anthony AlanVP, Chief Accounting Officer A Award2015-01-192015-01-2160,000$0.01 $600147,936SEC↗
SAMANT VIJAY BPresident & CEO S Sale2015-01-132015-01-144,737$1.12 $5.3K910,776SEC↗
BILINSKY IGORSr VP, Corporate Development S Sale2015-01-122015-01-141,335$1.16 $1.5K126,313SEC↗
SMITH LAWRENCE RUSSELLVP, Vaccine Research S Sale2015-01-122015-01-141,912$1.16 $2.2K174,977SEC↗
SAMANT VIJAY BPresident & CEO G Gift2014-12-262014-12-295,300— $0915,513SEC↗
SAMANT VIJAY BPresident & CEO G Gift2014-12-232014-12-23321— $0920,813SEC↗
SAMANT VIJAY BPresident & CEO G Gift2014-12-222014-12-2315,379— $0921,134SEC↗
SAMANT VIJAY BPresident & CEO A Award deriv2014-12-182014-12-18175,000— $0175,000SEC↗
Ramos Anthony AlanVP, Chief Accounting Officer S Sale2014-10-212014-10-22428$1.18 $50587,936SEC↗
SMITH LAWRENCE RUSSELLVP, Vaccine Research S Sale2014-10-132014-10-141,912$1.08 $2.1K176,889SEC↗
BILINSKY IGORSr VP, Corporate Development S Sale2014-10-132014-10-141,335$1.08 $1.4K127,648SEC↗
SAMANT VIJAY BPresident & CEO S Sale2014-10-132014-10-144,738$1.13 $5.4K936,513SEC↗
Ramos Anthony AlanVP, Chief Accounting Officer S Sale2014-08-262014-08-2712,500$1.25 $15.6K88,364SEC↗
SMITH LAWRENCE RUSSELLVP, Vaccine Research S Sale2014-08-262014-08-2712,500$1.25 $15.6K178,801SEC↗
BILINSKY IGORSenior VP, Corporate Dev't S Sale2014-08-262014-08-2712,500$1.25 $15.6K128,983SEC↗
Ramos Anthony AlanVP, Chief Accounting Officer S Sale2014-07-212014-07-21428$1.29 $552100,864SEC↗
SAMANT VIJAY BPresident & CEO S Sale2014-07-142014-07-154,737$1.17 $5.5K941,251SEC↗
SMITH LAWRENCE RUSSELLVP, Vaccine Research S Sale2014-07-112014-07-151,912$1.16 $2.2K191,301SEC↗
BILINSKY IGORSenior VP, Corporate Dev't S Sale2014-07-112014-07-151,335$1.16 $1.5K141,483SEC↗
SHERWIN STEPHEN ADirector A Award deriv2014-05-222014-05-2350,000— $050,000SEC↗
MORROW GEORGE JDirector A Award deriv2014-05-222014-05-2350,000— $050,000SEC↗
MERTON ROBERT CDirector A Award deriv2014-05-222014-05-2350,000— $050,000SEC↗
LYONS GARY ADirector A Award deriv2014-05-222014-05-2350,000— $050,000SEC↗
Beleson Richard MDirector A Award deriv2014-05-222014-05-2350,000— $050,000SEC↗
DOUGLAS R GORDONDirector A Award deriv2014-05-222014-05-2365,000— $065,000SEC↗
SHERWIN STEPHEN ADirector A Award2014-05-222014-05-237,500$0.01 $7514,503SEC↗
MORROW GEORGE JDirector A Award2014-05-222014-05-237,500$0.01 $7519,847SEC↗
MERTON ROBERT CDirector A Award2014-05-222014-05-237,500$0.01 $7583,281SEC↗
LYONS GARY ADirector A Award2014-05-222014-05-237,500$0.01 $7570,781SEC↗
Beleson Richard MDirector A Award2014-05-222014-05-237,500$0.01 $7514,578SEC↗
DOUGLAS R GORDONDirector A Award2014-05-222014-05-237,500$0.01 $75100,781SEC↗
Ramos Anthony AlanVP, Chief Accounting Officer S Sale2014-04-212014-04-21428$1.22 $522101,292SEC↗
SAMANT VIJAY BPresident & CEO S Sale2014-04-142014-04-154,738$1.16 $5.5K945,988SEC↗
BILINSKY IGORSenior VP, Corporate Dev't S Sale2014-04-112014-04-141,150$1.21 $1.4K142,818SEC↗
SMITH LAWRENCE RUSSELLVP, Vaccine Research S Sale2014-04-112014-04-141,912$1.21 $2.3K193,213SEC↗
Ramos Anthony AlanChief Accounting Officer F Tax w/h2014-01-242014-01-27209$1.49 $311101,720SEC↗
Ramos Anthony AlanChief Accounting Officer F Tax w/h2014-01-232014-01-2782$1.59 $130101,929SEC↗
Ramos Anthony AlanChief Accounting Officer F Tax w/h2014-01-212014-01-22164$1.66 $272102,011SEC↗
Ramos Anthony AlanChief Accounting Officer F Tax w/h2014-01-192014-01-22164$1.66 $272102,175SEC↗
BILINSKY IGORSenior VP, Corporate Dev't F Tax w/h2014-01-132014-01-14305$1.34 $409143,968SEC↗
SMITH LAWRENCE RUSSELLVP, Vaccine Research F Tax w/h2014-01-132014-01-14305$1.34 $409195,125SEC↗
SAMANT VIJAY BPresident & CEO F Tax w/h2014-01-132014-01-141,464$1.34 $2.0K950,726SEC↗
BILINSKY IGORSenior VP, Corporate Dev't F Tax w/h2014-01-112014-01-141,419$1.42 $2.0K144,273SEC↗
SMITH LAWRENCE RUSSELLVP, Vaccine Research F Tax w/h2014-01-112014-01-141,501$1.42 $2.1K195,430SEC↗
SMITH LAWRENCE RUSSELLVP, Vaccine Research F Tax w/h2014-01-112014-01-14491$1.42 $697196,931SEC↗
SAMANT VIJAY BPresident & CEO F Tax w/h2014-01-112014-01-142,623$1.42 $3.7K959,588SEC↗
SAMANT VIJAY BPresident & CEO F Tax w/h2014-01-112014-01-147,398$1.42 $10.5K952,190SEC↗
BILINSKY IGORSenior VP, Corporate Dev't A Award deriv2014-01-102014-01-14135,000— $0540,826SEC↗
SMITH LAWRENCE RUSSELLVP, Vaccine Research A Award deriv2014-01-102014-01-14135,000— $0717,850SEC↗
Ramos Anthony AlanChief Accounting Officer A Award deriv2014-01-102014-01-142— $0359,602SEC↗
Ramos Anthony AlanChief Accounting Officer A Award deriv2014-01-102014-01-1499,998— $0459,600SEC↗
SAMANT VIJAY BPresident & CEO A Award deriv2014-01-102014-01-14500,000— $02,809,000SEC↗
BILINSKY IGORSenior VP, Corporate Dev't P Buy2014-01-102014-01-1490,000$1.42 $127.8K145,692SEC↗
SMITH LAWRENCE RUSSELLVP, Vaccine Research P Buy2014-01-102014-01-1490,000$1.42 $127.8K197,422SEC↗
Ramos Anthony AlanChief Accounting Officer P Buy2014-01-102014-01-1470,000$1.42 $99.4K102,339SEC↗
SAMANT VIJAY BPresident & CEO P Buy2014-01-102014-01-14330,000$1.42 $468.6K962,211SEC↗
Ramos Anthony AlanChief Accounting Officer A Award2014-01-102014-01-1570,000$0.01 $700102,339SEC↗
BILINSKY IGORSenior VP, Corporate Dev't A Award2014-01-102014-01-1590,000$0.01 $900143,968SEC↗
SMITH LAWRENCE RUSSELLVP, Vaccine Research A Award2014-01-102014-01-1590,000$0.01 $900195,125SEC↗
SAMANT VIJAY BPresident & CEO A Award2014-01-102014-01-15330,000$0.01 $3.3K950,726SEC↗
SMITH LAWRENCE RUSSELLVP, Vaccine Research F Tax w/h2014-01-072014-01-08655$1.31 $858107,422SEC↗
BILINSKY IGORSenior VP, Corporate Dev't F Tax w/h2014-01-072014-01-0854$1.31 $7155,692SEC↗
Ramos Anthony AlanChief Accounting Officer S Sale2013-11-122013-11-147,918$1.11 $8.8K32,339SEC↗
Ramos Anthony AlanChief Accounting Officer F Tax w/h2013-10-232013-10-2482$1.49 $12240,257SEC↗
Ramos Anthony AlanChief Accounting Officer F Tax w/h2013-10-212013-10-21163$1.36 $22240,339SEC↗
Ramos Anthony AlanChief Accounting Officer F Tax w/h2013-10-192013-10-21163$1.34 $21840,502SEC↗
SAMANT VIJAY BPresident & CEO F Tax w/h2013-10-132013-10-151,463$1.29 $1.9K632,211SEC↗
SAMANT VIJAY BPresident & CEO F Tax w/h2013-10-112013-10-112,621$1.29 $3.4K633,674SEC↗
SINGER JAMES R10% Owner S Sale2013-09-122013-09-12200,000$1.29 $258.0K8,670,000SEC↗
SINGER JAMES R10% Owner S Sale2013-09-112013-09-12300,000$1.30 $390.0K8,870,000SEC↗
SINGER JAMES R10% Owner S Sale2013-09-102013-09-12200,000$1.23 $246.0K9,170,000SEC↗
SINGER JAMES R10% Owner S Sale2013-09-092013-09-10200,000$1.22 $244.0K9,370,000SEC↗
SINGER JAMES R10% Owner S Sale2013-09-042013-09-04216,000$1.22 $263.5K9,570,000SEC↗
SINGER JAMES R10% Owner S Sale2013-09-032013-09-04250,000$1.26 $315.0K9,786,000SEC↗
SINGER JAMES R10% Owner S Sale2013-08-302013-09-0384,000$1.31 $110.0K10,036,000SEC↗
SINGER JAMES R10% Owner S Sale2013-08-292013-08-30150,000$1.30 $195.0K10,120,000SEC↗
SINGER JAMES R10% Owner S Sale2013-08-282013-08-30200,000$1.31 $262.0K10,270,000SEC↗
Ramos Anthony AlanChief Accounting Officer A Award deriv2013-08-262013-08-27150,000— $0359,600SEC↗
Ramos Anthony AlanChief Accounting Officer P Buy2013-08-262013-08-2725,000$0.01 $25040,665SEC↗
ROLLAND ALAIN P PHDExec VP, Product Development F Tax w/h2013-08-222013-08-2313,527$1.33 $18.0K127,583SEC↗
SAMANT VIJAY BPresident & CEO G Gift2013-08-052013-08-071,400— $0636,295SEC↗
Ramos Anthony AlanChief Accounting Officer F Tax w/h2013-07-232013-07-2483$3.35 $27815,665SEC↗
Ramos Anthony AlanChief Accounting Officer F Tax w/h2013-07-212013-07-22164$3.62 $59415,748SEC↗
Ramos Anthony AlanChief Accounting Officer F Tax w/h2013-07-192013-07-22164$3.62 $59415,912SEC↗
SAMANT VIJAY BPresident & CEO F Tax w/h2013-07-132013-07-151,471$3.73 $5.5K637,695SEC↗
ROLLAND ALAIN P PHDExec VP, Product Development F Tax w/h2013-07-132013-07-15592$3.73 $2.2K172,542SEC↗
SAMANT VIJAY BPresident & CEO F Tax w/h2013-07-112013-07-152,635$3.72 $9.8K639,166SEC↗
ROLLAND ALAIN P PHDExec VP, Product Development F Tax w/h2013-07-112013-07-151,097$3.72 $4.1K173,134SEC↗
ROLLAND ALAIN P PHDExec VP, Product Development F Tax w/h2013-07-072013-07-081,317$3.61 $4.8K174,231SEC↗
MERTON ROBERT CDirector A Award deriv2013-05-232013-05-2839,619— $0298,741SEC↗
DOUGLAS R GORDONDirector A Award deriv2013-05-232013-05-2852,048— $0453,296SEC↗
MORROW GEORGE JDirector A Award deriv2013-05-232013-05-2839,619— $075,894SEC↗
Beleson Richard MDirector A Award deriv2013-05-232013-05-2840,176— $040,176SEC↗
LYONS GARY ADirector A Award deriv2013-05-232013-05-2839,619— $0284,678SEC↗
SHERWIN STEPHEN ADirector A Award deriv2013-05-232013-05-2840,176— $040,176SEC↗
MERTON ROBERT CDirector P Buy2013-05-232013-05-285,953$0.01 $6075,781SEC↗
DOUGLAS R GORDONDirector P Buy2013-05-232013-05-285,953$0.01 $6093,281SEC↗
MORROW GEORGE JDirector P Buy2013-05-232013-05-285,953$0.01 $6012,347SEC↗
Beleson Richard MDirector P Buy2013-05-232013-05-287,003$0.01 $707,078SEC↗
LYONS GARY ADirector P Buy2013-05-232013-05-285,953$0.01 $6063,281SEC↗
SHERWIN STEPHEN ADirector P Buy2013-05-232013-05-287,003$0.01 $707,003SEC↗
MERTON ROBERT CDirector M Exercise deriv2013-05-102013-05-1312,500— $0259,122SEC↗
MERTON ROBERT CDirector M Exercise2013-05-102013-05-1312,500$3.59 $44.9K69,828SEC↗
Ramos Anthony AlanChief Accounting Officer F Tax w/h2013-04-232013-05-3182$3.63 $29816,076SEC↗
Ramos Anthony AlanChief Accounting Officer F Tax w/h2013-04-212013-05-31164$3.81 $62516,158SEC↗
Ramos Anthony AlanChief Accounting Officer F Tax w/h2013-04-192013-05-31164$3.81 $62516,322SEC↗
Ramos Anthony AlanChief Accounting Officer A Award deriv2013-04-162013-04-1870,000— $070,000SEC↗
ROLLAND ALAIN P PHDExec VP, Product Development F Tax w/h2013-04-132013-04-15593$4.13 $2.4K175,548SEC↗
SAMANT VIJAY BPresident & CEO F Tax w/h2013-04-132013-04-151,471$4.13 $6.1K641,801SEC↗
ROLLAND ALAIN P PHDExec VP, Product Development F Tax w/h2013-04-112013-04-151,098$4.10 $4.5K176,141SEC↗